Media

What Influences Pharmaceutical Companies to Disclose Clinical Trial Results... Or Not?As many as 83% of clinical trial results do not reach the public domain within one year of their trial end date (Anderson et al, 2015). Many never even make it at all. Why do so many pharmaceutical companies hesitate to disclose their (valuable) results? Could the behavior of their peers and competitors have something to do with it? To address these questions, a study on firms sponsoring clinical trials was carried out by Professor Vedran Capkun of HEC Paris, and his co-authors Yun Lou, Clemens A. Otto, and Yin Wang, all from Singapore Management University.

KNOWLEDGE@HEC

22 Dec 2023 | What Influences Pharmaceutical Companies to Disclose Clinical Trial Results... Or Not?

Ganjiang International Accounting Forum, JUFE, Nanchang, China 18 November 2023

5 Dec 2023 | Presenter of the paper "Riding Attention Spikes: How Analysts Respond to Advertising" at the 2nd Ganjiang International Accounting Forum, JUFE Nanchang, China on 18 November 2023

21 Nov 2023 | 2nd Ganjiang International Accounting Forum news release, JUFE Nanchang, China on 18 November 2023

Joint School Conference 2023 - Tilburg and SMU 16-17 June 2023

2 Aug 2023 | Presenter of the paper "Common Ownership and Advertising" at the Joint School Conference 2023 - Tilburg and SMU on 16-17 June 2023

HeadHunt Postgraduate Fair Masterclass Session

17 Feb 2023 | Understanding Private Equity: An Investor Perspective

SMU SoA Teaching Excellence Awards for 2022

13 Aug 2022 | SMU SoA Most Promising Teacher Award 2022

Our heartiest congratulations... - SMU School of AccountancyOur heartiest congratulations to the following SoA faculty who have clinched SOA Teaching Excellence Awards and SOA Research Excellence Awards for 2022!...

SMU SoA Teaching Excellence Awards for 2021

28 Aug 2021 | SMU SoA Most Promising Teacher Award 2021

Congratulations to the... - SMU School of AccountancyCongratulations to the following professors who clinched SOA Teaching Excellence Awards and SOA Research Awards in 2021! Now that term has started, don't...

"Trendy! Tianjin" broadcast on Tianjin Television (TJTV) Science and Education Channel

7 Jun 2021 | Interviewed and served for alumni testimonial for Tianjin Foreign Languages School (天津外国语学校) in the TV Program "潮天津Trendy! Tianjin" broadcast on Tianjin Television (TJTV) Science and Education Channel 中国天津电视台科教频道 (video recording: 2’59” - 4’08”).

Essais cliniques : la transparence est bénéfique pour la santé publique… mais aussi pour les investisseursEn diminuant l’asymétrie d’information, les données sur ce type d’études aident notamment les acteurs des marchés financiers à évaluer l’avantage concurrentiel des entreprises pharmaceutiques.

THE CONVERSATION

3 Dec 2020 | Essais cliniques : la transparence est bénéfique pour la santé publique… mais aussi pour les investisseurs

KNOWLEDGE@HEC

16 Apr 2020 | Clinical Trial Transparency is Good for Public Health... and for Investors

Clinical Trial Transparency is Good for Public Health... and for InvestorsWhen it comes to life-saving – but also potentially risky – drugs, there is no such thing as too much information. Increasing transparency about clinical trials benefits public health, as a study of US regulation in the pharmaceutical sector shows. The three researchers behind this innovative study argue that transparency and public scrutiny also bring benefits to the investors of pharmaceutical companies.

Setting Speed Limits On Financial Reporting & Clinical Trial Disclosures - Asian Scientist MagazineTwo studies on the financial and pharmaceutical industries highlight the protective role of regulations and the human cost when companies place self-interest over compliance.

Asian Scientist Magazine

13 Jun 2019 | Setting Speed Limits On Financial Reporting & Clinical Trial Disclosures

Speaker on "The Real Effects of Clinical Trial Disclosures"

Research@SMU

9 May 2019 | May 2019 issue | Setting speed limits on financial reporting and clinical trial disclosures

Speaker on "The Real Effects of Clinical Trial Disclosures"

The 2018 HEC Foundation best PhD Thesis awarded to Yin WangCongratulations Yin! Best PhD Thesis awarded to Yin Wang (HEC PhD 2018) for his " Essays on Corporate Disclosure " under the direction of Vedran Capkun, HEC Associate Professor of Accounting and Management Control. Yin Wang has joined the Singapore Management University as Assistant Professor of Accounting.

The 2018 HEC Foundation Best PhD Thesis awarded to Yin Wang

22 Jan 2019 | HEC Paris

Yin Wang | Assistant Professor of Accounting | Singapore Management University | ywang@smu.edu.sg | +65 6808 5420

SMU webpage: https://accountancy.smu.edu.sg/faculty/profile/686/yin-wang